The global burden of urinary bladder cancer

References

• Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer 2006; 6: 603–12
   PubMed Web of Science ®Google Scholar
• Parkin DM, Chen VW, Ferlay J, Galceran J, Storm HH, Whelan SL. Comparability and quality control in cancer registration. IARC Technical Report No 19. IARC, Lyon 1994
   Google Scholar
• Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, et al. Cancer survivorship – genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 2005; 98: 15–25
   Google Scholar
• IARC/IACR Working Group. International rules for multiple primary cancers (ICD-O 3rd edition). Eur J Cancer Prev 2005;14:307–8.
   PubMed Web of Science ®Google Scholar
• Ebele JN, Sauter G, Epstein JI, Sesterhenn IA, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC; 2004.
   Google Scholar
• Hafner C, Knuechel R, Stoehr R, Hartmann A. Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies. Int J Cancer 2002; 101: 1–6
   PubMed Web of Science ®Google Scholar
• Koss LG. Mapping of the urinary bladder: its impact on the concepts of bladder cancer. Hum Pathol 1979; 10: 533–48
   PubMed Web of Science ®Google Scholar
• Aben KKH, Witjes JA, van Dijck JAAM, Schalken JA, Verbeek ALM, Kiemeny LALM. Lower incidence of urothelial carcinoma due to the concept of a clonal origin. Eur J Cancer 2000; 36: 2385–9
   PubMed Web of Science ®Google Scholar
• UICC. TNM Classification of malignant tumours. 6th ed. New York: Wiley & Sons; 2002.
   Google Scholar
• Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP. Biology and management of bladder cancer. N Engl J Med 1990; 322: 1129–38
   PubMed Web of Science ®Google Scholar
• Bostwick DG. Natural history of early bladder cancer. J Cell Biochem Suppl 1992; 16I: 31–8
   PubMedGoogle Scholar
• Koss LG. Natural history and patterns of invasive cancer of the bladder. Eur Urol 1998; 33(Suppl 4)2–4
   PubMedGoogle Scholar
• Hankey BF, Edwards BK, Ries LA, Percy CL, Shambaugh E. Problems in cancer surveillance: delineating in situ and invasive bladder cancer. J Natl Cancer Inst 1991; 83: 384–5
   PubMedGoogle Scholar
• Crow P, Ritchie AW. National and international variation in the registration of bladder cancer. BJU Int 2003; 92: 563–6
   PubMed Web of Science ®Google Scholar
• Saxen EA. Trends, facts or fallacy?. Trends in cancer incidence, causes and practical implications, K Magnus. Hemisphere, Washington, DC 1982; 5–16
   Google Scholar
• Kiemeney LA, Coebergh JW, Koper NP, van der Heijden LH, Pauwels RP, Schapers RF, Verbeek AL. Bladder cancer incidence and survival in the south-eastern part of The Netherlands 1975–1989. Eur J Cancer 1994; 30A: 1134–7
   PubMed Web of Science ®Google Scholar
• Whelan SL. Classification and coding. In: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, Cancer incidence in five continents, Vol VIII. IARC Scientific Publications No 155. Lyon: IARC; 2002.
   Google Scholar
• Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al. EUROCARE-3: survival of cancer patients diagnosed 1990–94 – results and commentary. Ann Oncol 2003; 14(Suppl 5)61–118
   PubMed Web of Science ®Google Scholar
• Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, , et al, SEER cancer statistics review 1975–2004. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2004/, based on November 2006 SEER data submission, posted to the SEER website 2007.
   Google Scholar
• World Health Organization. WHO Statistical Information System (WHOSIS). Table 3: Estimated completeness of mortality data for latest year. http://www.who.int/whosis/database/mort/table3.cfm.
   Google Scholar
• Puffer RR, Wynne Griffith G. Patterns of urban mortality. Scientific Publication No 151. Pan American Health Organization, Washington, DC 1967
   Google Scholar
• Percy C, Stanek E, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981; 71: 242–50
   PubMed Web of Science ®Google Scholar
• Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002 cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No 5, version 2.0. Lyon: IARC; 2004.
   Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005; 55: 74–108
   PubMed Web of Science ®Google Scholar
• Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, Cancer incidence in five continents IX. IARC Scientific Publications No 160. Lyon: IARC; 2007.
   Google Scholar
• Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. IARC Scientific Publications No 121. IARC, Lyon 1993
   Google Scholar
• Thörn M, Bergström R, Johansson AM, Ramström L, Persson I, Malmström PU. Trends in urinary bladder cancer incidence in Sweden 1960–93 with special reference to histopathology, time period, birth cohort, and smoking. Cancer Causes Control 1997; 8: 560–7
   PubMed Web of Science ®Google Scholar
• Swerdlow AJ, dos Santos Silva I, Reid A, Qiao Z, Brewster DH, Arrundale J. Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br J Cancer 1998; 77(Suppl 3)1–54
   PubMedGoogle Scholar
• Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 2007; 12: 20–37
   PubMed Web of Science ®Google Scholar
• Parkin D, Whelan S, Ferlay J, Storm H. Cancer incidence in five continents, Vols I–VIII. IARC CancerBase No 7. Lyon: IARC; 2005.
   Google Scholar
• World Health Organization. Mortality database. Geneva: WHO. http://www.who.int/healthinfo/morttables/en/index.html.
   Google Scholar
• Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer Feb 13, 2008 (epub ahead of print). doi:10.1016/j.ejca.2007.12.015
   Google Scholar
• Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda 1960–1997. Br J Cancer 2000; 82: 1585–92
   PubMed Web of Science ®Google Scholar
• Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case–control studies. Int J Cancer 2000; 86: 289–94
   PubMed Web of Science ®Google Scholar
• IARC monographs on the evaluation of carcinogenic risks to humans. Tobacco smoke and involuntary smoking, Vol 83. Lyon: IARC; 2004.
   Google Scholar
• Lopez AD, Mathers CD, Ezzati M, Jamison D, Murray CJL. Global burden of disease and risk factors. Oxford University Press and the World Bank, Washington, DC 2006
   Google Scholar
• Bosch FX, Cardis E. Cancer incidence correlations: genital, urinary and some tobacco-related cancers. Int J Cancer 1990; 46: 178–84
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Airoldi L. Human bladder cancer: epidemiological, pathological and mechanistic aspects. IARC Sci Publ 1999;(147):139–57.
   PubMedGoogle Scholar
• Blot WJ, Fraumeni JF, Jr. Geographic patterns of bladder cancer in the United States. J Natl Cancer Inst 1978; 61: 1017–23
   PubMed Web of Science ®Google Scholar
• IARC monographs on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori. Vol 61. Lyon: IARC; 1994.
   Google Scholar
• Utroska JA, Chen MG, Dixon H, Yoon S, Helling-Borda M, Hogerzeil HV, Mott KE. An estimate of global needs for praziquantel within schistosomiasis control programmes. WHO/SCHISTO/89.102. Division of Control of Tropical Diseases, WHO, Geneva 1989
   Google Scholar
• Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 3030–44
   PubMed Web of Science ®Google Scholar
• Miller BA, Kolonel LN, Bernstein L, Young JL, Jr, Swanson GM, West D, , et al, Racial/ethnic patterns of cancer in the United States 1988–1992. NIH Publication No 96-4104. Bethesda, MD: National Cancer Institute; 1996.
   Google Scholar
• Bouchardy C, Parkin DM, Wanner P, Khlat M. Cancer mortality among north African migrants in France. Int J Epidemiol 1996; 25: 5–13
   PubMed Web of Science ®Google Scholar
• Bouchardy C, Wanner P, Parkin DM. Cancer mortality among sub-Saharan African migrants in France. Cancer Causes Control 1995; 6: 539–44
   PubMed Web of Science ®Google Scholar
• García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005; 366: 649–59
   PubMed Web of Science ®Google Scholar
• Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE, Ross RK. Acetylator phenotype, aminobiphenyl–hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst 1994; 86: 712–6
   PubMed Web of Science ®Google Scholar
• Yu MC, Ross RK, Chan KK, Henderson BE, Skipper PL, Tannenbaum SR, Coetzee GA. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black, and Asian smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 1995; 4: 861–4
   PubMed Web of Science ®Google Scholar